DRUG-DELIVERY STUDIES IN CACO-2 MONOLAYERS .2. ABSORPTION ENHANCER EFFECTS OF LYSOPHOSPHATIDYLCHOLINES

Citation
L. Hovgaard et al., DRUG-DELIVERY STUDIES IN CACO-2 MONOLAYERS .2. ABSORPTION ENHANCER EFFECTS OF LYSOPHOSPHATIDYLCHOLINES, International journal of pharmaceutics, 114(2), 1995, pp. 141-149
Citations number
27
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
03785173
Volume
114
Issue
2
Year of publication
1995
Pages
141 - 149
Database
ISI
SICI code
0378-5173(1995)114:2<141:DSICM.>2.0.ZU;2-W
Abstract
This paper concerns the mechanistic elucidation of a certain class of absorption enhancers within the group of phospholipids, lysophosphatid ylcholines. The studies were performed in Caco-2 monolayers. Physico-c hemical characteristics and effects on the integrity and viability of the Caco-2 monolayers were found to be correlated with the absorption promoting effects of the phospholipids. Comparing enhancers with varyi ng size of the lipophilic moiety, the lipophilicity was shown to be of the utmost importance for all of the observed effects. As the chain l ength increased from 6 to 16 methylene groups, the effects measured on the monolayers were amplified. The acute effects were evaluated by va rious microscopic staining techniques as well as by transport studies. The transport rates of the vasopressin analogue 1-deamino-8-D-arginin e-vasopressin (DDAVP) were determined as a measure of the monolayer in tegrity. Based on the apparent permeability coefficient, P-app, it cou ld be concluded that phospholipid treatment increased DDAVP transport even under circumstances where the cell monolayer integrity was only s lightly altered.